Skip to main content
SpringerLink
Log in
Book cover

Klinische Neurologie pp 1–18Cite as

Migräne

  • Living reference work entry
  • First Online:

  • 323 Accesses

Part of the book series: Springer Reference Medizin ((SRM))

Zusammenfassung

Kopfschmerzen gehören zu den am häufigsten beklagten Symptomen überhaupt. Die Klassifikationskriterien der Internationalen Kopfschmerzgesellschaft (International Headache Society, IHS) definiert alle Kopfschmerzerkrankungen und bildet die Grundlage zur Einordnung von Kopfschmerzen. In der aktuell dritten Auflage der Internationalen Kopfschmerzklassifikation (ICHD-3) werden die bekannten primären und sekundären Kopfschmerzsyndrome beschrieben, kommentiert und in insgesamt 14 Kapitel eingeteilt. Die Kapitel 1–4 behandeln die primären Kopfschmerzformen wie Migräne, Spannungskopfschmerz, Clusterkopfschmerz, alle weiteren trigeminoautonomen Kopfschmerzen und andere seltene primäre Kopfschmerzerkrankungen, Kapitel 5–12 die sekundären Kopfschmerzen wie Subarachnoidalblutungen, intrazerebrale Blutungen oder die Riesenzellarteriitis, Kapitel 13 schmerzhafte Läsionen der Gehirnnerven und andere Gesichtsschmerzen und Kapitel 14 die nicht klassifizierbaren Formen. Trotz der großen Zahl möglicher Diagnosen kann man davon ausgehen, dass die Kenntnis der ca. 20–30 wichtigsten Kopfschmerzsyndrome und Differenzialdiagnosen ausreicht, um im klinischen Alltag über 95 % aller präsentierten Fälle einordnen zu können. Die gesamte Klassifikation mit allen Details kann auf der Webseite https://ichd-3.org/de/ abgerufen werden. Ausgewählte wichtige Kopfschmerzformen werden im Folgenden in der Reihenfolge der Kapitel der IHS-Klassifikation dargestellt. In diesem Kapitel wird die Migräne besprochen, weitere Kopfschmerzformen in Kap. „Spannungskopfschmerzen“, „Clusterkopfschmerzen und andere trigeminoautonome Kopfschmerzerkrankungen“, „Sonstige Kopfschmerzerkrankungen“ und „Sekundäre Kopfschmerzsyndrome“. Alle diagnostischen und therapeutischen Angaben entsprechen im Wesentlichen den Empfehlungen und Leitlinien der Deutschen Gesellschaft für Neurologie (DGN) und der Deutschen Migräne- und Kopfschmerzgesellschaft (DMKG) und können ausführlicher auf deren Webseiten nachgelesen werden.

This is a preview of subscription content, log in via an institution.

Literatur

Zitierte Literatur

  • Adams AM et al (2015) The impact of chronic migraine: the Chronic Migraine Epidemiology and Outcomes (CaMEO) study methods and baseline results. Cephalalgia 35(7):563–578

    Article  PubMed  PubMed Central  Google Scholar 

  • Afridi SK et al (2013) A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology 80(7):642–647

    Article  CAS  PubMed  Google Scholar 

  • Arkless K, Argunhan F, Brain SD (2019) CGRP discovery and timeline. Handb Exp Pharmacol 255:1–12

    Google Scholar 

  • Aurora SK, Brin MF (2017) Chronic migraine: an update on physiology, imaging, and the mechanism of action of two available pharmacologic therapies. Headache: J Head Face Pain 57(1):109–125

    Article  Google Scholar 

  • Baillie LE, Gabriele JM, Penzien DB (2014) A systematic review of behavioral headache interventions with an aerobic exercise component. Headache: J Head Face Pain 54(1):40–53

    Article  Google Scholar 

  • Cameron C et al (2015) Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache: J Head Face Pain 55:221–235

    Article  Google Scholar 

  • Charles A (2018) The migraine aura. Continuum: Lifelong learn Neurol 24(4):1009–1022

    PubMed  Google Scholar 

  • De Fusco M et al (2003) Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33(2):192

    Article  PubMed  CAS  Google Scholar 

  • DeLange JM, Cutrer FM (2014) Our evolving understanding of migraine with aura. Curr Pain Headache Rep 18(10):453

    Article  PubMed  Google Scholar 

  • Detke HC et al (2018) Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study. Neurology 91(24):e2211–e2221

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dichgans M et al (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366(9483):371–377

    Article  CAS  PubMed  Google Scholar 

  • Diener H-C et al (2012) Chronic migraine – classification, characteristics and treatment. Nat Rev Neurol 8(3):162

    Article  CAS  PubMed  Google Scholar 

  • Diener H-C et al (2015) Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options. Clin Med 15(4):344–350

    Article  Google Scholar 

  • Dodick DW (2018) A phase-by-phase review of migraine pathophysiology. Headache: J Head Face Pain 58:4–16

    Article  Google Scholar 

  • Dodick DW et al (2018) Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial. JAMA 319(19):1999–2008

    Article  CAS  PubMed  Google Scholar 

  • Edvinsson L (2018) The CGRP pathway in migraine as a viable target for therapies. Headache: J Head Face Pain 58:33–47

    Article  Google Scholar 

  • Elbadawi A et al (2019) Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine. Acta Cardiol 74(2):124–129

    Article  PubMed  Google Scholar 

  • Evans RW, Grosberg BM (2008) Expert opinion: retinal migraine: migraine associated with monocular visual symptoms (CME). Headache: J Head Face Pain 48(1):142–145

    Article  Google Scholar 

  • Gelfand AA (2018) Pediatric and adolescent headache. CONTINUUM: Lifelong Learn Neurol 24(4):1108–1136

    Google Scholar 

  • Giffin NJ et al (2016) The migraine postdrome: an electronic diary study. Neurology 87(3):309–313

    Article  PubMed  PubMed Central  Google Scholar 

  • Goadsby PJ, Holland PR (2019) An update: pathophysiology of migraine. Neurol Clin 37(4):651–671

    Article  PubMed  Google Scholar 

  • Goadsby PJ et al (2017) A controlled trial of erenumab for episodic migraine. N Engl J Med 377(22):2123–2132

    Article  CAS  PubMed  Google Scholar 

  • Greene K, Irwin SL, Gelfand AA (2019) Pediatric migraine: an update. Neurol Clin 37(4):815–833

    Article  PubMed  Google Scholar 

  • Hay DL, Walker CS (2017) CGRP and its receptors. Headache: J Head Face Pain 57(4):625–636

    Article  Google Scholar 

  • Karsan N, Prabhakar P, Goadsby P (2017) Premonitory symptoms of migraine in childhood and adolescence. Curr Pain Headache Rep 21(7):34

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kropp P et al (2016) Entspannungsverfahren und verhaltenstherapeutische Interventionen zur Behandlung der Migräne. Nervenheilkunde 35(07/08):502–515

    Article  Google Scholar 

  • Lampl C et al (2005) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76(12):1730–1732

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lampl C et al (2015) Neck pain in episodic migraine: premonitory symptom or part of the attack? J Headache pain 16(1):80

    Article  PubMed Central  Google Scholar 

  • Laurell K, Lundström E (2012) Migrainous infarction: aspects on risk factors and therapy. Curr Pain Headache Rep 16(3):255–260

    Article  PubMed  Google Scholar 

  • Linde K et al (2016) Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev (6):CD001218. https://doi.org/10.1002/14651858.CD001218.pub3

  • MaassenVanDenBrink A et al (2016) Wiping out CGRP: potential cardiovascular risks. Trends Pharmacol Sci 37(9):779–788

    Article  CAS  PubMed  Google Scholar 

  • May A, Burstein R (2019) Hypothalamic regulation of headache and migraine. Cephalalgia 39(13):1710–1719

    Article  PubMed  PubMed Central  Google Scholar 

  • Olesen J (2018) Headache classification committee of the International Headache Society (IHS) The international classification of headache disorders, asbtracts. Cephalalgia 38(1):1–211

    Article  Google Scholar 

  • Ong JJY, Wei DY, Goadsby PJ (2018) Recent advances in pharmacotherapy for migraine prevention: from pathophysiology to new drugs. Drugs 78:411–437. https://doi.org/10.1007/s40265-018-0865-y

    Article  CAS  PubMed  Google Scholar 

  • Ophoff RA et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87(3):543–552

    Article  CAS  PubMed  Google Scholar 

  • Puledda F, Messina R, Goadsby PJ (2017) An update on migraine: current understanding and future directions. J Neurol 264(9):2031–2039

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Russell MB, Ducros A (2011) Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 10(5):457–470

    Article  PubMed  Google Scholar 

  • Schwedt TJ (2014) Chronic migraine. BMJ 348:g1416

    Article  PubMed  Google Scholar 

  • Shah DR, Dilwali S, Friedman DI (2018) Current aura without headache. Curr Pain Headache Rep 22(11):77

    Article  PubMed  Google Scholar 

  • Silberstein SD et al (2017) Fremanezumab for the preventive treatment of chronic migraine. N Engl J Med 377(22):2113–2122

    Article  CAS  PubMed  Google Scholar 

  • Skljarevski V et al (2018) Efficacy and safety of galcanezumab for the prevention of episodic migraine: results of the EVOLVE-2 phase 3 randomized controlled clinical trial. Cephalalgia 38(8):1442–1454

    Article  PubMed  Google Scholar 

  • Stauffer VL et al (2018) Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial. JAMA neurology 75(9):1080–1088

    Article  PubMed  PubMed Central  Google Scholar 

  • Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11(4):289

    Article  PubMed  PubMed Central  Google Scholar 

  • Tepper S et al (2017) Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 16(6):425–434

    Article  CAS  PubMed  Google Scholar 

  • Thissen S et al (2014) Persistent migraine aura: new cases, a literature review, and ideas about pathophysiology. Headache: J Head Face Pain 54(8):1290–1309

    Article  Google Scholar 

  • Thorlund K et al (2017) Comparative tolerability of treatments for acute migraine: a network meta-analysis. Cephalalgia 37(10):965–978

    Article  PubMed  Google Scholar 

  • Viana M et al (2017) Clinical features of migraine aura: results from a prospective diary-aided study. Cephalalgia 37(10):979–989

    Article  PubMed  Google Scholar 

  • Vongvaivanich K et al (2015) Late-life migraine accompaniments: a narrative review. Cephalalgia 35(10):894–911

    Article  PubMed  Google Scholar 

Weiterführende Literatur

  • Abu-Arafeh I et al (2010) Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol 52(12):1088–1097

    Article  Google Scholar 

  • Akerman S, Holland PR, Goadsby PJ (2011) Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci 12(10):570

    Article  CAS  PubMed  Google Scholar 

  • Barbanti P, Aurilia C, Dall’Armi V, Egeo G, Fofi L, Bonassi S (2016) The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization. A case series of 757 patients. Cephalalgia 36:1334–1340

    Article  CAS  PubMed  Google Scholar 

  • Burch R (2020) Epidemiology and treatment of menstrual migraine and migraine during pregnancy and lactation: a narrative review. Headache: J Head Face Pain 60(1):200–216

    Article  Google Scholar 

  • Calhoun AH et al (2010) The prevalence of neck pain in migraine. Headache: J Head Face Pain 50(8):1273–1277

    Article  Google Scholar 

  • Charles A (2018) The pathophysiology of migraine: implications for clinical management. Lancet Neurology 17(2):174–182

    Article  CAS  PubMed  Google Scholar 

  • Charles A (2018) The migraine aura. Continuum: Lifelong learn Neurol 24(4):1009–1022

    Google Scholar 

  • Charlesworth BR et al (2003) Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine. Cns Drugs 17(9):653–667

    Article  CAS  PubMed  Google Scholar 

  • Cortelli P et al (2011) Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies. Neurol Sci 32(1):95–98

    Article  Google Scholar 

  • DeLange JM, Cutrer FM (2014) Our evolving understanding of migraine with aura. Curr Pain Headache Rep 18(10):453

    Google Scholar 

  • Derry CJ, Derry S, Moore RA (2012a) Sumatriptan (intranasal route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev (2):CD009663. https://doi.org/10.1002/14651858.CD009663

  • Derry CJ, Derry S, Moore RA (2012b) Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev (2):CD009665. https://doi.org/10.1002/14651858.CD009665

  • Derry CJ, Derry S, Moore RA (2012c) Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev (2):CD008615. https://doi.org/10.1002/14651858.CD008615.pub2

  • Derry CJ, Derry S, Moore RA (2014) Sumatriptan (all routes of administration) for acute migraine attacks in adults-overview of Cochrane reviews. Cochrane Database Syst Rev 5

    Google Scholar 

  • Dodick D et al (2005) Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine. CNS drugs 19(2):125–136

    Article  CAS  PubMed  Google Scholar 

  • Ernst E (1999) Homeopathic prophylaxis of headaches and migraine? A systematic review. J Pain Symptom Manag 18(5):353–357

    Article  CAS  Google Scholar 

  • Evans R, Aurora S (2012) Migraine with persistent visual aura. Headache 52(3):494–501

    Article  PubMed  Google Scholar 

  • Gawel M et al (2005) Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine – results from phase 1 of the REALIZE Study. Headache: J Head Face Pain 45(1):7–16

    Article  Google Scholar 

  • Giffin N et al (2003) Premonitory symptoms in migraine: an electronic diary study. Neurology 60(6):935–940

    Article  CAS  PubMed  Google Scholar 

  • Goadsby PJ, Holland PR (2019) An update: pathophysiology of migraine. Neurol Clin 37(4):651–671

    Article  PubMed  Google Scholar 

  • Hansen JM, Goadsby PJ, Charles AC (2016) Variability of clinical features in attacks of migraine with aura. Cephalalgia 36(3):216–224

    Article  PubMed  Google Scholar 

  • Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 6(10):573

    Article  CAS  PubMed  Google Scholar 

  • Holroyd KA et al (2010) Effect of preventive (β blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ 341:c4871

    Article  PubMed  PubMed Central  Google Scholar 

  • Kirchmann M, Thomsen LL, Olesen J (2006) Basilar-type migraine: clinical, epidemiologic, and genetic features. Neurology 66(6):880–886

    Article  PubMed  Google Scholar 

  • Koseoglu E et al (2015) The role of exercise in migraine treatment. J Sports Med Phys Fit 55(9):1029–1036

    CAS  Google Scholar 

  • Kowacs PA, Utiumi MA, Piovesan EJ (2015) The visual system in migraine: from the bench side to the office. Headache: J Head Face Pain 55:84–98

    Article  Google Scholar 

  • Kropp P et al (2017) Entspannungsverfahren und verhaltenstherapeutische Interventionen zur Behandlung der Migräne. Schmerz 31(5):433–447

    Article  CAS  PubMed  Google Scholar 

  • Kruit MC et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291(4):427–434

    Article  CAS  PubMed  Google Scholar 

  • Kruit MC et al (2005) Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 128(9):2068–2077

    Article  PubMed  Google Scholar 

  • Laurell K et al (2011) Migrainous infarction: a Nordic multicenter study. Eur J Neurol 18(10):1220–1226

    Article  CAS  PubMed  Google Scholar 

  • Leao AA (1944) Spreading depression of activity in the cerebral cortex. J Neurophysiol 7(6):359–390

    Article  Google Scholar 

  • Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR (2009) Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev (1):CD001218. https://doi.org/10.1002/14651858.CD001218.pub2

  • Mattle HP et al (2015) Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J 37(26):2029–2036

    Article  Google Scholar 

  • Messlinger K, Fischer MJ, Lennerz JK (2011) Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine. Keio J Med 60(3):82–89

    Article  CAS  PubMed  Google Scholar 

  • Miglis MG (2018) Migraine and autonomic dysfunction: which is the horse and which is the jockey? Curr Pain Headache Rep 22(3):19

    Article  PubMed  Google Scholar 

  • Nestoriuc Y et al (2008) Biofeedback treatment for headache disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback 33(3):125–140

    Article  PubMed  Google Scholar 

  • Ong JJY, Wei DY-T, Goadsby PJ (2018) Recent advances in pharmacotherapy for migraine prevention: from pathophysiology to new drugs. Drugs 1–27

    Google Scholar 

  • Oskoui M et al (2019) Practice guideline update summary: acute treatment of migraine in children and adolescents: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 93(11):487–499

    Article  PubMed  Google Scholar 

  • Overath CH et al (2014) Does an aerobic endurance programme have an influence on information processing in migraineurs? J Headache Pain 15(1):11

    Article  PubMed  PubMed Central  Google Scholar 

  • Patniyot IR, Gelfand AA (2016) Acute treatment therapies for pediatric migraine: a qualitative systematic review. Headache: J Head Face Pain 56(1):49–70

    Article  Google Scholar 

  • Plato BM (2016) Rare complications of migraine with aura. Headache: J Head Face Pain 56(8):1373–1379

    Article  Google Scholar 

  • Pradhan S, Chung SM (2004) Retinal, ophthalmic, or ocular migraine. Current Neurol Neurosci Rep 4(5):391–397

    Article  Google Scholar 

  • Reilinger T (2014) Genetik primärer Kopfschmerzen. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 57(8):919–927

    Article  Google Scholar 

  • Rozen TD (2015) Emergency department and inpatient management of status migrainosus and intractable headache. Continuum: Lifelong Learn Neurol 21(4):1004–1017

    Google Scholar 

  • Schulte LH, Jürgens TP, May A (2015) Photo-, osmo-and phonophobia in the premonitory phase of migraine: mistaking symptoms for triggers? J Headache Pain 16(1):14

    Article  PubMed  PubMed Central  Google Scholar 

  • Silberstein SD (1995) Migraine symptoms: results of a survey of self-reported migraineurs. Headache: J Head Face Pain 35(7):387–396

    Article  CAS  Google Scholar 

  • Straube A, Andreou A (2019) Primary headaches during lifespan. J Headache Pain 20(1):35

    Article  PubMed  PubMed Central  Google Scholar 

  • Terrin A et al (2018) When migraine mimics stroke: a systematic review. Cephalalgia 38(14):2068–2078

    Article  PubMed  Google Scholar 

  • Tfelt-Hansen PC (2011) Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register. J Headache Pain 12(4):399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thorlund K et al (2014) Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis. Cephalalgia 34(4):258–267

    Article  PubMed  Google Scholar 

  • Vécsei L et al (2018) Treating status migrainosus in the emergency setting: what is the best strategy? Expert Opin Pharmacother 19(14):1523–1531

    Article  PubMed  CAS  Google Scholar 

  • Vgontzas A, Burch R (2018) Episodic migraine with and without aura: key differences and implications for pathophysiology, management, and assessing risks. Curr Pain Headache Rep 22(12):78

    Article  PubMed  Google Scholar 

  • Walach H et al (1997) Classical homeopathic treatment of chronic headaches. Cephalalgia 17(2):119–126

    Article  CAS  PubMed  Google Scholar 

  • Walach H et al (2000) The long-term effects of homeopathic treatment of chronic headaches: 1 year follow up. Cephalalgia 20(9):835–837

    Article  CAS  PubMed  Google Scholar 

  • Wallasch T-M, Kropp P (2012) Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study. J Headache Pain 13(7):521

    Article  PubMed  PubMed Central  Google Scholar 

  • Wallasch TM, Angeli A, Kropp P (2012) Outcomes of a headache-specific cross-sectional multidisciplinary treatment program. Headache: J Head Face Pain 52(7):1094–1105

    Article  Google Scholar 

  • Whitmarsh T, Coleston-Shields D, Steiner T (1997) Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine. Cephalalgia 17(5):600–604

    Article  CAS  PubMed  Google Scholar 

  • Xu H et al (2016) Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. J Headache Pain 17(1):113

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yoon M et al (2012) Prevalence of primary headaches in Germany: results of the German Headache Consortium Study. J Headache Pain 13(3):215

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologischer Konsiliardienst, Neurologische Klinik und Poliklinik der LMU München, München, Deutschland

    Stefanie Förderreuther

  2. Neurologische Klinik und Poliklinik der LMU, Großhadern, München, Deutschland

    Katharina Kamm

Authors
  1. Stefanie Förderreuther
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katharina Kamm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefanie Förderreuther .

Editor information

Editors and Affiliations

  1. Essen, Germany

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Förderreuther, S., Kamm, K. (2020). Migräne. In: Berlit, P. (eds) Klinische Neurologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44768-0_79-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-44768-0_79-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-44768-0

  • Online ISBN: 978-3-662-44768-0

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation